Scientific Opinion on Exploring options for providing advice about possible human health risks based on the concept of Threshold of Toxicological Concern (TTC)
2012; Wiley; Volume: 10; Issue: 7 Linguagem: Inglês
10.2903/j.efsa.2012.2750
ISSN1831-4732
Tópico(s)Pesticide Exposure and Toxicity
ResumoEFSA JournalVolume 10, Issue 7 2750 OpinionOpen Access Scientific Opinion on Exploring options for providing advice about possible human health risks based on the concept of Threshold of Toxicological Concern (TTC) EFSA Scientific Committee, EFSA Scientific CommitteeSearch for more papers by this author EFSA Scientific Committee, EFSA Scientific CommitteeSearch for more papers by this author First published: 02 July 2012 https://doi.org/10.2903/j.efsa.2012.2750Citations: 90 Scientific committee members: Boris Antunovic, Susan Barlow, Andrew Chesson, Albert Flynn, Anthony Hardy, Michael-John Jeger, Ada Knaap, Harry Kuiper, David Lovell, Birgit Nørrung, Iona Pratt, Alicja Mortensen, Josef Schlatter, Vittorio Silano, Frans Smulders and Philippe Vannier Correspondence: [email protected] Acknowledgement: The Scientific Committee wishes to thank the members of the Working Group on Threshold of Toxicological Concern for the preparatory work for this scientific opinion: Susan Barlow, Alan Boobis, James Bridges, Astrid Bulder, Corrado Galli (member until February 2011), Ursula Gundert-Remy, John Christian Larsen, Jean-Claude Lhuguenot, David Lovell, Alberto Mantovani, Aldert Piersma, Josef Schlatter, Andrew Worth and Giovanni Zapponi (member until May 2011); hearing expert Sylvia Escher and EFSA staff members Daniela Maurici and Hans Steinkellner. Adoption date: 22 May 2012 Published date: 2 July 2012 Question number: EFSA-Q-2008-747 On request from: EFSA AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract Synthetic and naturally occurring substances present in food and feed, together with their possible breakdown or reaction products, represent a large number of substances, many of which require risk assessment. EFSA's Scientific Committee was requested to evaluate the threshold of toxicological concern (TTC) approach as a tool for providing scientific advice about possible human health risks from low level exposures, its applicability to EFSA's work, and to advise on any additional data that might be needed to strengthen the underlying basis of the TTC approach. The Scientific Committee examined the published literature on the TTC approach, undertook its own analyses and commissioned an in silico investigation of the databases underpinning the TTC approach. The Scientific Committee concluded that the TTC approach can be recommended as a useful screening tool either for priority setting or for deciding whether exposure to a substance is so low that the probability of adverse health effects is low and that no further data are necessary. The following human exposure threshold values are sufficiently conservative to be used in EFSA's work; 0.15 μg/person per day for substances with a structural alert for genotoxicity, 18 μg/person per day for organophosphate and carbamate substances with anti-cholinesterase activity, 90 μg/person per day for Cramer Class III and Cramer Class II substances, and 1800 μg/person per day for Cramer Class I substances, but for application to all groups in the population, these values should be expressed in terms of body weight, i.e. 0.0025, 0.3, 1.5 and 30 μg/kg body weight per day, respectively. Use of the TTC approach for infants under the age of 6 months, with immature metabolic and excretory systems, should be considered on a case-by-case basis. The Committee defined a number of exclusion categories of substances for which the TTC approach would not be used. References Abraham K, Mielke H, Huisinga W, Gundert-Remy; U, 2005. Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration. Archives of Toxicology 79: 63– 73. Adler ID, 1990. Clastogenic effects of acrylamide in different germ-cell stages of male mice. In: JW Allen, BA Bridges, MF Lyon, MJ Moses, JB Russell, (Eds.), Banbury Report 34: Biology of Mammalian Germ Cell Mutagenesis, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 115– 131. Adler ID, Reitmeir P, Schmöller R, Schriever-Schwemmer; G, 1994. Dose response for heritable translocations induced by acrylamide in spermatids of mice. Mutation Research 309: 285– 291. AFSSA, 2005. Seuil de préoccupation toxicologique pour l'analyse de risque sanitaire des substances chimiques dans les aliments. Mai 2005. Agence Francaise de Securité Sanitaire des Aliments. Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman; P, Selby PB, 1995. Cyclophosphamide: a review of its mutagenicity for an assessment of potential germ cell risks. Mutation Research 330: 1156– 181. Ashby J, Tennant RW, 1991. Definitive relationships among chemical structure, carcinogenicity, and mutagenicity for 301 chemicals tested by the US NTP. Mutation Research 257: 229– 306. Australian Guidelines, 2008. Australian Guidelines for Water Recycling: Augmentation of Drinking Water Supplies 2008. Environment Protection and Heritage Council, National Health and Medical Research Council, Natural Resource Management Ministerial Council. Barlow S, 2005. Threshold of toxicological concern: a tool for assessing substances of unknown toxicity present at low levels in the diet. ILSI Concise Monograph Series, ISBN 1-57881-188-0, ILSI Press, Washington DC and Brussels. Baron JM, Wiederholt T, Heise R, Merk H F, Bickers DR, 2008. Expression and function of cytochrome p450-dependent enzymes in human skin cells. Current Medicinal Chemistry 15: 2258– 64. Bassan A, Worth AP, 2008. The integrated use of models for the properties and effects of chemicals by means of a structured workflow. QSAR and Combinatorial Science (QCS) 27: 6– 20. Bassan A, Fioravanzo E, Pavan M, Stocchero M, 2011. Applicability of physicochemical data, QSARs and read-across in Threshold of Toxicological Concern assessment. Final report of a study carried out by Soluzioni Informatiche (S-In;, Vicenza, Italy) for the European Food Safety Authority (EFSA). Available at: www.efsa.europa.eu/en/supporting/pub/159e.htm Benigni R, Bossa C, Jeliazkova N, Netzeva T, Worth A, 2008. The Benigni / Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree. JRC Scientific and Technical Report EUR 23241 EN. Publications Office of the European Union, Luxembourg. Available at: publications.jrc.ec.europa.eu/repository/ Benigni R, Bossa C, Tcheremenskaia O, Giuliani A, 2010. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays. Expert Opinion on Drug Metabolism & Toxicology 6: 809– 819. Bernauer U, Heinemeyer G, Heinrich-Hirsch; B, Ulbrich B, Gundert-Remy; U, 2008. Exposure-triggered reproductive toxicity testing under the REACH legislation: A proposal to define significant/relevant exposure. Toxicology letters 176: 68– 76. Bitsch A, Jacobi S, Melber C, Wahnschaffe U, Simetska N, Mangelsdorf I, 2006. REPDOSE: A database on repeated dose toxicity studies of commercial chemicals-A multifunctional tool. Regulatory Toxicology and Pharmacology 46: 202– 210. Blackburn K, Stickney JA, Carlson-Lynch; HL, McGinnis PM, Chappell L, Felter SP, 2005. Application of the threshold of toxicological concern approach to ingredients in personal and household care products. Regulatory Toxicology and Pharmacology 43: 249– 259. Boehnlein J, Sakr A, Lichtin J L, Bronaughm R L, 1994. Characterization of esterase and alcohol dehydrogenase activity in skin: metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption. Pharmaceutical Research 11: 1145– 1159. Boobis A, Gundert-Remy; U, Kremers P, Macheras P and Pelkonen O, 2002. In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15. European Journal of Pharmaceutical Sciences 17: 183– 193. Brüschweiler BJ, 2010a. The TTC concept. Method of assessment of contaminants of unknown toxicity in drinking water. Gas-Wasser;-Abwasser 4: 295– 303. Brüschweiler BJ, 2010b. TTC-based risk assessment of tetrachlorobutadienes and pentachlorobutadienes-the in vitro genotoxic contaminants in ground and drinking water. Regulatory Toxicology and Pharmacology 58: 341– 344. Carthew P, Clapp C, Gutsell S, 2009. Exposure-based waiving: The application of the toxicological threshold of concern (TTC) to inhalation exposure for aerosol ingredients in consumer products. Food and Chemical Toxicology 47: 1287– 1295. Cheeseman M A, Machuga E J, Bailey A B, 1999. A tiered approach to threshold of regulation. Food and Chemical Toxicology 37: 331– 338. Clayton B, Kroes R, Larsen JC, Pascal G, 1998. Applicability of the ADI to infants and children. Food Additives & Contaminants, 15: Supplement, pp 1– 89. Collins F S, Gray G M, Bucher J R, 2008. Transforming environmental health protection. Science, 319: 906– 907. Cramer G M, Ford R A, Hall R L, 1978. Estimation of toxic hazard - a decision tree approach. Food and Cosmetic Toxicology 16: 255– 276. CRD, 2010. Proposal for a revision of the guidance document on dermal absorption. Project report from contract CT/EFSA/PPR/2009/02. Chemicals Regulation Directorate, UK. Available from: www.efsa.europa.eu/en/scdocs/doc/52e.pdf. Csanády GA, Kessler W, Hoffmann HD, Filser JG, 2003. A toxicokinetic model for styrene and its metabolite styrene-7, 8-oxide in mouse, rat and human with special emphasis on the lung. Toxicology Letters 138: 75– 102. De Wolf W, Siebel-Sauer; A, Lecloux A, Koch V, Holt M, Feijtel T, Comber M, Boeije G, 2005. Mode of action and aquatic exposure thresholds of no concern. Environmental Toxicology and Chemistry 24: 479– 485. De Zwart LL, Haenen HEMG, Versantvoort CHM, Sips AJAM, 2002. Pharmacokonetics of ingested xenobiotics in children: A comparison with adults. RIVM report 623860011/2002, RIVM, Holland. Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ, 1995. Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutation Research 330: 71– 99. Dekant W, Melching-Kollmu;ß S, Kalberlah F, 2010. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products. Regulatory Toxicology and Pharmacology 56: 135– 142. Dollery CT, Davis DS, Conolly ME, 1971. Differences in the metabolism of drugs depending on their routes of administration. Annals of the New York Academy of Sciences 179: 108– 114. Dorne JL and Renwick AG, 2005. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicological Sciences, 86: 20– 26. Drew R, Frangos J, 2007. The concentration of no toxicological concern (CoNTC): A risk assessment screening tool for air toxics. Journal of Toxicology and Environmental Health, Part A70: 1584– 1593. EC, 1997. European Workshop on the Impact of Endocrine Disrupters on Human Health and the Environment. Weybridge, United Kingdom, 2–4 December 1996. Cat. No. EUR 17549. Office of Official Publications of the European Communities, Luxembourg. EC, 1998. Report on methodologies for the monitoring of food additive intake across the European Union (Final report submitted by the Task Co-ordinator 16 January 1998). Reports of a working Group on Scientific Co-operation on questions relating to food. Task 4.2. SCOOP/INT/REPORT/2. European Commission, Directorate General III Industry, Brussels. EC, 2002. Commission Decision of 23 January 2002 amending Commission Decision 1999/217/EC as regards the register of flavouring substances used in or on foodstuffs. Official Journal of the European Communities. L 49/1-160, 20.2.2002. Available at: eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=iJ:L:2002:049:0001:0160:EN:PDF EC, 2004. Guidance document on dermal absorption. European Commission DG SANCO/222/2000 rev.7; 19th March 2004. Available from: ec.europa.eu/food/plant/protection/evaluation/guidance/wrkdoc20_rev_en.pdf EC, 2007. Corrigendum to Regulation (EC) No.1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the registration, evaluation, authorization and restriction of chemicals (REACH), establishing a European Chemicals Agency, amending Directive199/45/EC and repealing Council regulation (EEC) No.793/93 and Commission Regulation (EC) No.1488/94 as well as Council Directive 76//769/EEC and Commission Directives 91/155/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union 136, 29.5.2007. Available at: eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=ij:l:2006:396:0001:0849:en:pdf EC, 2008. SCCP/SCHER/SCENIHR: request for a scientific opinion on the Use of the Threshold of Toxicological Concern (TTC) approach for the health risk assessment of chemicals. Available at: ec.europa.eu/health/archive/ph_risk/documents/ttc_mandate.pdf EC-JRC;, 2009. Proceedings of the 1st International Forum Towards Evidence-Based; Toxicology, Como, Italy 15–18 October 2007. Human and Experimental Toxicology 28: 71– 165. EC, 2011. 4th report on the implementation of the "Community Strategy for Endocrine Disrupters" a range of substances suspected of interfering with the hormone systems of humans and wildlife (COM (1999) 706). Commission Staff Working Paper. Brussels, 10.8.2011. SEC (2011) 1001 final. Available at: ec.europa.eu/environment/endocrine/documents/sec_2011_1001_en.pdf. ECB, 2008. Risk Assessment Vinyl Acetate, CAS#: 108-05-4, EINECS#: 203-545-4. European Chemicals Bureau, 19.08.2008. Available at: esis.jrc.ec.europa.eu/doc/existing-chemicals/risk_assessment/REPORT/vinylacetatereport059.pdf ECETOC, 1995. Assessment factors in human health risk assessment. In: Technical reports European Chemical Industry Ecology and Toxicology Centre. Technical Report 68, ECETOC, Brussels ECHA, 2008. Guidance on information requirements and chemical safety assessment. Chapter R.5: Adaptation of information requirements. May 2008. European Chemicals Agency. Available at: guidance.echa.europa.eu/docs/guidance_document/information_requirements_r5_en.pdf?vers=20_08_08. EFSA, 2005a. Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for risk assessment of substances which are both Genotoxic and Carcinogenic. European Food Safety Authority. The EFSA Journal 282, 1– 3. Available at: www.efsa.europa.eu/en/efsajournal/doc/282.pdf. EFSA, 2006. Guidance of the Scientific Committee on a request from EFSA related to Uncertainties in Dietary Exposure Assessment. European Food Safety Authority. The EFSA Journal 438: 29– 54. Available at: www.efsa.europa.eu/en/efsajournal/doc/438.pdf. EFSA, 2007. Opinion of the Scientific Committee on a request from EFSA on the introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. European Food Safety Authority. The EFSA Journal 587: 1– 16. Available at: www.efsa.eu.int/EFSA/efsa_locale-1178620753812_1178667590178.htm. EFSA, 2008a. Guidance Document for the use of the Concise European Food Consumption Database in Exposure Assessment. European Food Safety Authority. Available at: www.efsa.europa.eu/cs/BlobServer/General/Coincise_database_guidance_document_and_annexes.pdf?ssbinary=yrue. EFSA, 2008b. Food Contact Materials. Note for Guidance. Updated on 30/07/08. Pp 63– 64. European Food Safety Authority. Available at: www.efsa.europa.eu/en/scdocs/doc/CEF_note_for_guidance_FCM_evaluation_2008.08.07.pdf. EFSA, 2009. The potential risks arising from nanoscience and nanotechnologies on food and feed safety. Scientific opinion of the Scientific Committee. Question No EFSA-Q-2007-124a. Adopted on 10 February 2009. European Food Safety Authority. Available at: www.efsa.europa.eu/en/scdocs/doc/sc_op_ej958_nano_en.pdf EFSA 2010b. Scientific report of the Endocrine Active Substances Task Force. European Food Safety Authority. The EFSA Journal 8(11): 1932 [ 59 pp.]. Available at: www.efsa.europa.eu/en/efsajournal/doc/1932.pdf. EFSA, 2010c. Management of left-censored data in dietary exposure assessment of chemical substances. European Food Safety Authority. The EFSA Journal, 8(3): 1557 [96p]. Available at: www.efsa.europa.eu/en/efsajournal/doc/1557.pdf. EFSA, 2010d. Public consultation of the Scientific Panel on Plant Protection Products and their Residues (PPR) on the Draft Guidance on Dermal Absorption and the Draft Scientific Opinion on the Science behind the Revision of the Guidance Document on Dermal Absorption. European Food Safety Authority. Available at: www.efsa.europa.eu/en/consultationsclosed/call/ppr101027.htm EFSA, 2010e. Guidance on the data required for the risk assessment of flavourings to be used in or on foods. European Food Safety Authority. The EFSA Journal 8(6): 1623. Available at: www.efsa.europa.eu/en/efsajournal/doc/1623.pdf EFSA, 2010f. Scientific Opinion on the safety and efficacy of Koffogran (nicarbazin) as a feed additive for chickens for fattening", March 2010. European Food Safety Authority. The EFSA Journal (2010): 8(23), 1551 [ 40pp]. Available at: www.efsa.europa.eu/en/scdocs/scdoc/1551.htm. EFSA, 2011a. Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. European Food Safety Authority. The EFSA Journal 9(5): 2140 [36p]. Available at: www.efsa.europa.eu/en/efsajournal/doc/2140.pdf. EFSA, 2011b. Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment. European Food Safety Authority. The EFSA Journal, 9(3): 2097 [ 34pp]. Available at: www.efsa.europa.eu/en/efsajournal/doc/2097.pdf. EFSA, 2011c. Scientific opinion on the risks for animal and public health related to the presence of Alternaria toxins in feed and food. European Food Safety Authority. The EFSA Journal, 9(10): 2407 [ 97pp]. Available at: www.efsa.europa.eu/en/efsajournal/doc/2407.pdf. EFSA, 2012. Guidance on selected default values to be used by the EFSA Scientific Panels and Committee, and EFSA Units in the absence of actual measured data. European Food Safety Authority. The EFSA Journal, 10(3):2579, [ 32pp]. Available at www.efsa.europa.eu/en/efsajournal/pub/2579.htm. Ehling UH, 1988. Quantification of the genetic risk of environmental mutagens. Risk Analysis 8: 45– 57. Ehling UH, Neuhäuser-Klaus; A, 1989. Induction of specific-locus mutations in male mice by ethyl methanesulfonate Mutation Research 227: 91– 95. Ehling UH, Neuhäuser-Klaus; A, 1992. Revaluation of the induction of specific-locus mutations in spermatogonia of the mouse by acrylamide. Mutation Research 283: 185– 191 EMEA, 2006. Guideline on the Limits of Genotoxic Impurities. Committee for Medicinal Products for Human Use (CPMP). European Medicines Agency. London, 28 June 2006, CPMP/SWP/5199/02. EMEA/CHMP/QWP/251344/2006. EMEA, 2007. Draft Guideline on the Assessment of Genotoxic Constituents in Herbal Substances/Preparations. Committee on herbal Medicinal Products (HMPC), European Medicines Agency. London, 31 October 2007, EMEA/HMPC/107079/2007. Escher SE, Tluczkiewicz I, Batke M, Bitsch A, Melber C, Kroese ED, Buist HE, Mangelsdorf I, 2010. Evaluation of inhalation TTC values with the database RepDose. Regulatory Toxicology and Pharmacology 58: 259– 274. Fawell J, 2008. Health risks of micropollutants-The need for a new approach. Water Science and Technology 57: 183– 187. FDA, 1993. Food additives: Threshold of Regulation for Substances Used in Food-Contact; Articles. Federal Register 58: 52719– 52729, Tuesday October 12, 1993. FDA, 1995. Food Additives: Threshold of Regulation for Substances Used in Food-Contact; Articles; Final Rule. Federal Register 60: 36582– 36596, Monday July 17, 1995. FDA, 2008. Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches. Draft Guidance. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), December 2008. Felter S, Lane R W, Latulippe M E, Llewellyn G C, Olin S S, Scimeca J A, Trautman T D, 2009. Refining the threshold of toxicological concern (TTC) for risk prioritization of trace chemicals in food. Food and Chemical Toxicology 47: 2236– 2245. Frawley, JP, 1967. Scientific evidence and common sense as a basis for food packaging regulations. Food and Cosmetics Toxicology 5: 293– 308. Fung V A, Barrett JC, Huff J, 1995. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environmental Health Perspectives 103: 680– 683. Ginsberg G, Hattis D, Sonawane B, 2004. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicology and Applied Pharmacology 198: 164– 183. Gold LS, Sawyer CB, Magaw R, Backman GM, de Veciana M, Levinson R, Hooper NK, Havender W R, Bernstein L, Peto R, Pike M, Ames BN, 1984. A carcinogenesis potency database of the standardized results of animal bioassays. Environmental Health Perspectives 58: 9– 319. Gold LS, Slone TH, Bernstein L, 1989. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database. Environmental Health Perspectives 79: 259– 272. LS Gold, E Zeiger (Eds.), 1997. Handbook of Carcinogenic Potency and Genotoxicity Databases. CRC Press, Boca Raton. Goldberg AM, Epstein LD, Zurlo J, 1997. A Modular Approach to Validation - A Work in Progress. In: Advances in Animal Alternatives for Safety and Efficacy Testing. Eds. Harry Salem and Sidney Katz. CRC Press, pp. 303– 308. Hansen SC, 1966. Acceptable daily intake of food additives and ceiling on levels of use. Food and Cosmetics Toxicology 4: 427– 432. Hansen SC, 1979. Condition for use of food additivies based on a budget for an acceptable daily intake. J. Food Protection, 42: 429– 434. Hildebrandt R, Wagner B, Preiss-Nowzohour; K, Gundert-Remy; U, 1994. Fenoterol metabolism in man: sulphation versus glucuronidation. Xenobiotica 24: 71– 74. Humfrey CDN, 2007. Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances. Toxicological Sciences 100: 24– 28. Hutchinson TH, Bögi C, Winter MJ, Owens JW, 2009. Benefits of the maximum tolerated dose (MTD) and maximum tolerated concentration (MTC) concept in aquatic toxicology. Aquatic Toxicology 91: 197– 202. IGHRC, 2006. Guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals. Published by the Institute of Environment and Health, Cranfield University, Silsoe, Bedfordshire, UK ILSI, 2000. Threshold of toxicological concern for chemical substances present in the diet. Report of a workshop held on 5–6 October 1999 in Paris, France. ISBN 1-57881-101-5, ILSI Press, Washington DC and Brussels. JRC, 2010. Applicability of QSAR analysis to the evaluation of the toxicological relevance of metabolites and degradates of pesticide active substances for dietary risk assessment. External Scientific Report. European Food Safety Authority. Available at: www.efsa.europa.eu/en/supporting/pub/50e.htm and at http://ihcp.jrc.ec.europa.eu/our_labs/computational_toxicology/doc/EUR_24748_EN.pdf. Kalkhof H, 2010. Toxikologische Risikobewertung chemischer Stoffe mittels eines probabilistischen Ansatzes-das TTC-Konzept;. Master thesis, University of Berlin, Germany. Kalkhof H, Herzler M, Stahlmann R, Gundert-Remy; U, 2012. Threshold of toxicological concern values for non-genotoxic effects in industrial chemicals: reevaluation of the Cramer classification. Archives of Toxicology 86:, 17– 25. Kalberlah F, Schneider K, 1998. Examination of the data as the basis for the quantification of extrapolation factors. Final report of the research project No. 116 06 113 of the Federal Environmental Agency 797. Kearns GL, Abdel-Rahman; SM, Alander SW, Blowey DL, Leede JS, Kauffman RE, 2003. Developmental pharmacology-drug disposition, action, and therapy in infants and children. New England Journal of Medicine 349: 1157– 1167. Kroes R, Galli C, Munro I, Schilter B, Tran L -A, Walker R, Wurtzen G, 2000. Threshold of toxicological Concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food and Chemical Toxicology 38: 255– 312. Kroes R, Renwick A G, Cheeseman M A, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos J G, Wurtzen G, 2004. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food and Chemical Toxicology 42: 65– 83. Kroes R, Kleiner J, Renwick A, 2005. The threshold of toxicological concern concept in risk assessment. Toxicological Sciences 86: 226– 230. Kroes R, Renwick A G, Feron V, Galli C L, Gibney M, Greim H, Guy R H, Lhuguenot JC, van de Sandt JJ, 2007. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food and Chemical Toxicology 45: 2533– 2562. Kulkarni S A, Zhu J, Blechinger S, 2005. In silico techniques for the study and prediction of xenobiotic metabolism: a review. Xenobiotica 35: 955– 973. Lapenna S, Worth A, 2011. Analysis of the Cramer classification scheme for oral systemic toxicity - implications for its implementation in Toxtree. JRC Scientific and Technical Report EUR 24898 EN. Publications Office of the European Union, Luxembourg. Available at: publications.jrc.ec.europa.eu/repository/ Laufersweiler MC, Gadagbui B, Baskerville-Abraham; IM, Maier A, Willis A, Scialli AR, Carr GJ, Felter SP, Blackburn K, Daston G, 2012. Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. Regulatory Toxicology and Pharmacology 62, 160– 182. Lewis SE, Barnett LB, Felton C, Johnson FM, Skow LC, Cacheiro N, Shelby MD, 1986. Dominant visible and electrophoretically expressed mutations induced in male mice exposed to ethylene oxide by inhalation. Environmental Mutagenesis. 8: 867– 872. McGregor D, Bolt H, Cogliano V, Richter-Reichhelm; HB, 2006. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the (2006) IPCS Human Framework for the Analysis of a cancer mode of action for humans. Critical Reviews in Toxicology 36: 821– 835. Melching-Kollmu;ß S, Dekant W, Kalberlah F, 2010. Application of the "threshold of toxicological concern" to derive tolerable concentrations of "non-relevant metabolites" formed from plant protection products in ground and drinking water. Regulatory Toxicology and Pharmacology 56: 126– 134. Merk HF, 2009. Drug skin metabolites and allergic drug reactions. Current Opinion in Allergy and Clinical Immunology 9: 311– 315. Mielke H, Gundert-Remy; U, 2009. Bisphenol A levels in blood depend on age and exposure. Toxicology Letters 190: 22– 40. Mostrag-Szlichtyng; A, Worth AP, 2010a. In silico modelling of microbial and human metabolism: a case study with the fungicide carbendazim. JRC Scientific and Technical Report EUR 24523 EN. Publications Office of the European Union, Luxembourg. Available at: publications.jrc.ec.europa.eu/repository/ Mostrag-Szlichtyng; A, Worth A, 2010b. Review of QSAR Models and Software Tools for predicting Biokinetic Properties. EUR 24377 EN. JRC Scientific and Technical Report EUR 24427 EN. Publications Office of the European Union, Luxembourg. Available at: publications.jrc.ec.europa.eu/repository/ Muller A, Blaude MN, Ihelmann C, Bjorge C, Ohlsson A, Gebel T. 2012. A regulatory approach to assess the potency of substances toxic to the reproduction. Regulat Toxicol Pharmacol 63; 1: 97– 105. Müller L, Mauthe RJ, Riley CM, Andino MM, De Antonis D, Beels C, DeGeorge J, De Knaep AGM, Ellison D, Fagerland JA, Frank R, Fritschel B, Galloway S, Harpur E, Humfrey CDN, Jacks AS, Jagota N, Mackinnon J, Mohan G, Ness DK, O'Donovan MR, Smith MD, Vudathala G, Yotti L, 2006. A rationale for determining, testing and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regulatory
Referência(s)